array:24 [ "pii" => "S2387020618305862" "issn" => "23870206" "doi" => "10.1016/j.medcle.2018.05.054" "estado" => "S300" "fechaPublicacion" => "2019-02-15" "aid" => "4557" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2018" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2019;152:e19-20" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775318303683" "issn" => "00257753" "doi" => "10.1016/j.medcli.2018.05.030" "estado" => "S300" "fechaPublicacion" => "2019-02-15" "aid" => "4557" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2019;152:e19-20" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 8 "formatos" => array:2 [ "HTML" => 4 "PDF" => 4 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Criptococosis meníngea en una paciente con diagnóstico de linfoma T angioinmunoblástico en tratamiento con alemtuzumab" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e19" "paginaFinal" => "e20" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Meningeal cryptococcosis in a patient with angioimmunoblastic lymphoma treated with alemtuzumab" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "David Cruz, Paula Costa, Miguel Sagüés" "autores" => array:3 [ 0 => array:2 [ "nombre" => "David" "apellidos" => "Cruz" ] 1 => array:2 [ "nombre" => "Paula" "apellidos" => "Costa" ] 2 => array:2 [ "nombre" => "Miguel" "apellidos" => "Sagüés" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020618305862" "doi" => "10.1016/j.medcle.2018.05.054" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020618305862?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775318303683?idApp=UINPBA00004N" "url" => "/00257753/0000015200000004/v1_201901310615/S0025775318303683/v1_201901310615/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020618305874" "issn" => "23870206" "doi" => "10.1016/j.medcle.2018.04.009" "estado" => "S300" "fechaPublicacion" => "2019-02-15" "aid" => "4564" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2019;152:e21" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Risk stratification of patients with pneumonia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "e21" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estratificación pronóstica de los pacientes con neumonía" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan González del Castillo, Carlota Clemente, María José Núñez Orantos" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Juan" "apellidos" => "González del Castillo" ] 1 => array:2 [ "nombre" => "Carlota" "apellidos" => "Clemente" ] 2 => array:2 [ "nombre" => "María José" "apellidos" => "Núñez Orantos" ] 3 => array:1 [ "colaborador" => "on behalf of INFURG-SEMES" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S002577531830397X" "doi" => "10.1016/j.medcli.2018.04.027" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577531830397X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020618305874?idApp=UINPBA00004N" "url" => "/23870206/0000015200000004/v1_201902100719/S2387020618305874/v1_201902100719/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020618305916" "issn" => "23870206" "doi" => "10.1016/j.medcle.2018.12.012" "estado" => "S300" "fechaPublicacion" => "2019-02-15" "aid" => "4554" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2019;152:164-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Microscopic polyangiitis and interstitial lung disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "164" "paginaFinal" => "165" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Poliangitis microscópica y enfermedad pulmonar intersticial" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 675 "Ancho" => 900 "Tamanyo" => 243761 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Slightly involved glomerulus (arrowhead) and glomerulus with damaged small blood vessels due to neutrophil infiltration that cause fibrinoid necrosis (asterisk). Immunofluorescence showed C3, C1q and IgM immune complex deposits, in small vessel walls.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ignacio Gayá García-Manso, Raquel García Sevila, Paloma Vela Casasempere" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Ignacio" "apellidos" => "Gayá García-Manso" ] 1 => array:2 [ "nombre" => "Raquel" "apellidos" => "García Sevila" ] 2 => array:2 [ "nombre" => "Paloma" "apellidos" => "Vela Casasempere" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775318303658" "doi" => "10.1016/j.medcli.2018.05.027" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775318303658?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020618305916?idApp=UINPBA00004N" "url" => "/23870206/0000015200000004/v1_201902100719/S2387020618305916/v1_201902100719/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Meningeal cryptococcosis in a patient with angioimmunoblastic lymphoma treated with alemtuzumab" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e19" "paginaFinal" => "e20" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "David Cruz, Paula Costa, Miguel Sagüés" "autores" => array:3 [ 0 => array:4 [ "nombre" => "David" "apellidos" => "Cruz" "email" => array:2 [ 0 => "davidcrzg@gmail.com" 1 => "dcruz@iconcologia.net" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Paula" "apellidos" => "Costa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Miguel" "apellidos" => "Sagüés" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Hematología Clínica, ICO-Girona, Hospital Universitario Dr. Josep Trueta, Girona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Laboratorio Clínico Territorial ICS Girona, Parque Sanitario Martí Julià, Girona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Criptococosis meníngea en una paciente con diagnóstico de linfoma T angioinmunoblástico en tratamiento con alemtuzumab" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Cryptococcosis is a serious opportunistic fungal disease caused by encapsulated yeasts belonging to the genus <span class="elsevierStyleItalic">Crytococcus</span>. Distribution is worldwide. This genus includes about 50 species, <span class="elsevierStyleItalic">Cryptococcus neoformans</span> and <span class="elsevierStyleItalic">Cryptococcus gattii</span> being the most frequent human pathogens. Depending on its capsular composition, 5 serotypes have been reported: A (<span class="elsevierStyleItalic">C. neoformans var. grubii</span>), D (<span class="elsevierStyleItalic">C. neoformans var. neoformans</span>) and AD (<span class="elsevierStyleItalic">C. neoformans hybrid</span>) and serotypes B and C (<span class="elsevierStyleItalic">C. gattii</span>). The main reservoir is soil contaminated with excrement, mostly from birds, bats and organic matter.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">1,2</span></a> It is acquired mainly by the respiratory route (inhaled), and rarely by the gastrointestinal tract and skin.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The estimated incidence in our country is 0.5/1,000,000 inhabitants.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The main risk factor is cellular immunodeficiency.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> The main risk groups include patients with HIV infection, oncohematological patients and transplant recipients.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">C. gattii</span> has traditionally been associated with the disease in immunocompetent individuals in tropical and subtropical regions.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The most common symptomatology includes headache in up to 75% cases, usually lasting about 2–4 weeks. Frequently it occurs with fever, nausea, vomiting and seizures, but neck stiffness and typical signs of meningism have been reported in fewer than 25% cases.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">The diagnosis is based on the identification of the yeasts in biological fluids, by observing the capsule in the India ink stain, the isolation in cultures or the detection of capsular antigens.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Treatment includes an induction phase with intravenous liposomal amphotericin B and oral flucytosine. After the normalization of cerebrospinal fluid (CSF) results, oral fluconazole is used for maintenance therapy.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Alemtuzumab is a recombinant monoclonal antibody that binds to CD52, present on B and T lymphocytes, monocytes, NK cells and some granulocytes. Lysis of CD52 positive cells occurs by complement activation, antibody-dependent cytotoxicity and apoptosis. It is indicated in the treatment of chronic lymphatic leukemia and other T-cell lymphoproliferative neoplasms. It causes dose-independent lymphopenia and increases the risk of developing opportunistic infections.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">We present a case report of meningeal cryptococcosis in a patient with angioimmunoblastic T-cell lymphoma and treated with alemtuzumab, in January 2016.</p><p id="par0050" class="elsevierStylePara elsevierViewall">A 57-year-old woman diagnosed with angioimmunoblastic T-cell lymphoma in June 2014. She received first-line chemotherapy in accordance with the R-CHOP regimen (rituximab, cyclophosphamide, adriamycin, vincristine and prednisone) for 6 cycles without obtaining a response; subsequently alemtuzumab was administered, which had to be withdrawn due to cytomegalovirus (CMV) infection. She underwent a third-line treatment with ciclosporin until progression and a fourth-line treatment with lenalidomide, without response. Eventually, she restarted treatment with alemtuzumab.</p><p id="par0055" class="elsevierStylePara elsevierViewall">The patient went to the emergency department due to a 4-day occipital headache, that awakened her at night, and disorientation, with no fever and no further symptoms.</p><p id="par0060" class="elsevierStylePara elsevierViewall">She was hemodynamically stable. Physical examination revealed a disorientation in time, space and person. She had neck stiffness and positive Kernig and Brudzinski signs. The complete blood count showed: hemoglobin 113<span class="elsevierStyleHsp" style=""></span>g/L, platelets 195<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">9</span>/L, leukocytes 6.59<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">9</span>/L (normal formula). Plasma coagulation and basic biochemistry were normal. The patient underwent a cranial computed tomography that showed no relevant pathological changes. The CSF study showed: glucose 36<span class="elsevierStyleHsp" style=""></span>mg/dL [50–80] and proteins 81.7<span class="elsevierStyleHsp" style=""></span>mg/dL [15–45]. Gram staining was negative for bacteria and pneumococcal antigen. The polymerase chain reaction tests for CMV, JC virus, Epstein-Barr virus, herpes simplex virus 1 and 2, varicella-zoster virus and <span class="elsevierStyleItalic">Listeria monocytogenes</span> were all negative. Given the suspicion of opportunistic infection, we used India ink stain which showed capsule yeasts.</p><p id="par0065" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">C. neoformans var. grubii</span> was isolated in the CSF culture.</p><p id="par0070" class="elsevierStylePara elsevierViewall">The patient underwent treatment with liposomal amphotericin B and flucytosine for 24 days, and she was discharged with maintenance oral fluconazole therapy, completing a 7-month treatment.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Cruz D, Costa P, Sagüés M. Criptococosis meníngea en una paciente con diagnóstico de linfoma T angioinmunoblástico y tratamiento con alemtuzumab. Med Clin (Barc). 2019;152:e19–e20.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cryptococcal meningitis: epidemiology and therapeutic options" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.J. Sloan" 1 => "V. Parris" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/CLEP.S38850" "Revista" => array:6 [ "tituloSerie" => "Clin Epidemiol" "fecha" => "2014" "volumen" => "6" "paginaInicial" => "169" "paginaFinal" => "182" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24872723" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic fungal infections in patients with human inmunodeficiency virus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C. Rodríguez-Cerdeira" 1 => "R. Arenas" 2 => "G. Moreno-Coutiño" 3 => "E. Vásquez" 4 => "R. Fernández" 5 => "P. Chang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2012.06.017" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2014" "volumen" => "105" "paginaInicial" => "5" "paginaFinal" => "17" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23107866" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estudio epidemiológico de la criptococosis en España: primeros resultados" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.F. Colom" 1 => "S. Frasés" 2 => "C. Ferrer" 3 => "E. Martín-Mazuelos" 4 => "M. Hermoso-de-Mendoza" 5 => "J.M. Torres-Rodríguez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Iberoam Micol" "fecha" => "2001" "volumen" => "18" "paginaInicial" => "99" "paginaFinal" => "104" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15487916" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D. Sloan" 1 => "S. Dlamini" 2 => "N. Paul" 3 => "M. Dedicoat" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2008" "paginaInicial" => "CD005647" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "BC Cancer. Monográfico alemtuzumab. Available from: <a id="intr0010" class="elsevierStyleInterRef" href="http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Alemtuzumab_Monograph_1May2015.pdf">http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Alemtuzumab_Monograph_1May2015.pdf</a> [accessed 24 Feb 2017]." ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015200000004/v1_201902100719/S2387020618305862/v1_201902100719/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015200000004/v1_201902100719/S2387020618305862/v1_201902100719/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020618305862?idApp=UINPBA00004N" ]
Journal Information
Vol. 152. Issue 4.
Pages e19-e20 (February 2019)
Share
Download PDF
More article options
Vol. 152. Issue 4.
Pages e19-e20 (February 2019)
Letter to the Editor
Meningeal cryptococcosis in a patient with angioimmunoblastic lymphoma treated with alemtuzumab
Criptococosis meníngea en una paciente con diagnóstico de linfoma T angioinmunoblástico en tratamiento con alemtuzumab
Visits
3
This item has received
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail